Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Evaluate the Safety and Efficacy of Apixaban”

13 trials

Showing 13 of 13 results

Testing effectiveness (Phase 2)Study completedNCT06205615
What this trial is testing

Treatment of Post-Punch Biopsy Bleeding in Apixaban-Treated Patients Using Self-Administered BXP154B

Who this might be right for
Wound Bleeding
Bio 54, LLC 24
Not applicableUnknownNCT04550637
What this trial is testing

A Multi-center Study of Apixaban(APPROACH)

Who this might be right for
Evaluate the Safety and Efficacy of Apixaban
Shanghai Zhongshan Hospital 200
Large-scale testing (Phase 3)Study completedNCT01780987
What this trial is testing

AStudy To Evaluate Safety And Eficacy Of Apixaban In Japanese Acute Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE) Patients

Who this might be right for
Deep Vein ThrombosisPulmonary Embolism
Pfizer 80
Large-scale testing (Phase 3)Study completedNCT00452530
What this trial is testing

Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery

Who this might be right for
Deep Vein ThrombosisPulmonary Embolism
Bristol-Myers Squibb 3,221
Large-scale testing (Phase 3)Study completedNCT00412984
What this trial is testing

Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation

Who this might be right for
Atrial FibrillationAtrial Flutter
Bristol-Myers Squibb 20,976
Large-scale testing (Phase 3)Active Not RecruitingNCT05757869
What this trial is testing

Milvexian Versus Apixaban in Participants With Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Janssen Research & Development, LLC 20,284
Large-scale testing (Phase 3)Study completedNCT00371683
What this trial is testing

Study of Apixaban for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery

Who this might be right for
Deep Vein ThrombosisPulmonary Embolism
Bristol-Myers Squibb 3,608
Testing effectiveness (Phase 2)Ended earlyNCT03594045
What this trial is testing

Efficacy and Safety of Apixaban in the Treatment of Heparin Induced Thrombocytopenia (HIT)

Who this might be right for
Heparin-induced ThrombocytopeniaHeparin-induced Thrombocytopenia and Thrombosis
Massachusetts General Hospital 5
Large-scale testing (Phase 3)Study completedNCT00423319
What this trial is testing

Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (ADVANCE-3)

Who this might be right for
Deep Vein ThrombosisPulmonary Embolism
Bristol-Myers Squibb 5,407
Large-scale testing (Phase 3)Ended earlyNCT00831441
What this trial is testing

Phase III Acute Coronary Syndrome

Who this might be right for
Acute Coronary Syndrome
Bristol-Myers Squibb 7,484
Not applicableWithdrawnNCT05116267
What this trial is testing

Assessment of the Effectiveness and Safety Outcome in Patients With Atrial Fibrillation Treated by Apixaban in Belgium

Who this might be right for
Atrial Fibrillation
Pfizer
Testing effectiveness (Phase 2)Study completedNCT03251482
What this trial is testing

Evaluate the Safety and Efficacy of Intravenous JNJ-64179375 Versus Oral Apixaban in Participants Undergoing Elective Total Knee Replacement Surgery

Who this might be right for
VTE Prophylaxis With Anticoagulation After Total Knee Replacement Surgery
Janssen Research & Development, LLC 308
Testing effectiveness (Phase 2)Study completedNCT00787150
What this trial is testing

Evaluate The Safety Of Apixaban In Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Pfizer 222

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation